Rebecca R. Vanderpool

Has grant

Assistant Professor

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rebecca R. Vanderpool is an Assistant Professor at The Ohio State University, USA. Her research focuses on pulmonary vascular diseases, particularly in relation to pulmonary hypertension and its implications for right ventricular function. Recent publications include investigations utilizing advanced imaging techniques and machine learning models to improve detection and treatment outcomes in patients with pulmonary vascular conditions.

Recent Grants

Grant: Close

Role of HIF-2a and Right Ventricular Fibrosis in the Development of Right Heart Failure and Pulmonary Hypertension

Open Date: 2019-04-01

Close Date: 2022-03-31

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Laura J. Niedernhofer

UNITED STATES

View details

Robert Frantz

Professor of Medicine

Mayo Clinic

UNITED STATES

View details

Nancy Casanova

Research Associate Professor

University of Florida

UNITED STATES

View details

Michael Patrick Gray

University of Sydney

AUSTRALIA

View details

honghui wang

National Institutes of Health

UNITED STATES

View details

Sasha Prisco

Assistant Professor

University of Minnesota

UNITED STATES

View details

Roberto J. Bernardo

UNITED STATES

View details

Zhiyu Dai

University of Arizona

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rebecca R. Vanderpool

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (19)

Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central computed tomography structures

Cluster analysis identifies quantitative CT imaging-based subgroups in COPD subjects with pulmonary artery enlargement

Right ventricular–pulmonary arterial coupling predicts mortality in precapillary pulmonary hypertension

Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series).

Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort

Imaging the Intersection of Parenchymal Abnormalities and Pulmonary Vascular Pathways

Pulmonary hypertension across the spectrum of left heart and lung disease.

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension

The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling.

Loss of DNA repair mechanisms in cardiac myocytes induce dilated cardiomyopathy.

iCPET Calculator: A Web‐Based Application to Standardize the Calculation of Alpha Distensibility in Patients With Pulmonary Arterial Hypertension

Advanced hemodynamic and cluster analysis for identifying novel RV function subphenotypes in patients with pulmonary hypertension.

Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease

Endothelial PHD2 deficiency induces nitrative stress <i>via</i> suppression of caveolin-1 in pulmonary hypertension.

Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience.

Increased RV:LV ratio on chest CT-angiogram in COVID-19 is a marker of adverse outcomes.

Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension.

Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension.

Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.

Collaborators (8)

Laura J. Niedernhofer

Robert Frantz

Nancy Casanova

Michael Patrick Gray

honghui wang

Sasha Prisco

Roberto J. Bernardo

Zhiyu Dai

Make your next move.